Artios is on a mission to kill cancer by exploiting DNA damage response (DDR) and repair pathways that are leveraged by cancer cells to promote their survival. Our specialized DcoDeR platform integrates Artios’ leadership capabilities, expertise and experience in DNA damage biology and drug discovery to systematically discover and develop medicines targeting the totality of the DDR. We have built an extensive DDR focused pipeline designed to address areas of high unmet needs across solid tumour indications including our ATR inhibitor, ART0380, and our Polθ inhibitor ART6043, as monotherapy and combination treatments. Together with our strategic partnerships with Merck KGaA and Novartis, and research collaborations with premiere institutions like Cancer Research UK, The Institute of Cancer Research, The Netherlands Cancer Institute, and the Crick Institute we are pioneering validated approaches to DDR drug discovery. Visit our website at https://www.artios.com/ for more information about the company and our pipeline.
Artios is based at the Babraham Campus in Cambridge, UK. If you are interested in working at Artios and have the qualities to be part of our team, please submit your application via our website. We are also very mindful of scams that involve recruitment. At this time please note we are currently not working with any third parties in India for recruitment.

Arix Bioscience

iBank

IP Group

EQT life science

Merck Capital Ventures

Andera Partners

Novartis Venture Fund

Pfizer Venture Investments

CaaS Capital Management

RTW Investments

Avidity Partners

Soleus Capital

Tetragon Financial Group Limited

Deep Track Capital

M Ventures

Piper Sandler

Merck

Darmstadt

Artios 

Marco Ranzani (Artios) and Sravanth Hindupur (Novartis) will be presenting the results of the ongoing collaboration between Artios and Novartis in our poster LB222: “Elucidating the cellular responses and mechanisms of action of 177Lu-based radioligand therapy”
The poster presentation will be on Monday April 8th 1.30-5.00 PDT (GMT-7) in Session Late-Breaking Research: Tumor Biology , Poster Section 54, Board Number 17.

The Artios Pharma team will be attending the upcoming American Association of Cancer Research (AACR) Annual Meeting in San Diego, CA. Interested to hear more about DNA damage response (#DDR) pathways and the progress being made with our novel clinical candidates? Graeme Smith, Marco Ranzani and Colleen Sadin will be onsite and available for meetings. 
Contact us at info@artiospharma.com 
#AACR24 #cancerdrugdevelopment  #DNAdamageresponse

We are thrilled and honoured to receive the Cancer Research Horizons - Start-Up Achievement Recognition Award, which was presented to us at the Innovation & Entrepreneurship Awards 2024 ceremony in London last night. 
This award recognises the significant progress we’ve made in our mission to target DNA damage response (#DDR) pathways for #cancerdrugdevelopment in the past 2 years. During that time, we have advanced several DDR products candidates targeting #breastcancer, #ovariancancer and other solid tumours in clinical development as well as presented promising initial clinical data at ESMO. We believe that developing breakthrough cancer treatments that target DDR pathways to specifically destroy certain devastating cancers that are difficult to treat will have a dramatic impact on patients’ lives. 
Thank you, Cancer Research Horizons for recognition of our vision. #oncology #drugdevelopment

At the 2024 DNA Damage, Mutation and Cancer Conference GRC on Monday (March 11), our Vice President of biology, Helen Robinson, will provide an update on the advances being made by Artios Pharma in targeting DNA damage response (#DDR) pathways for #cancerdrugdevelopment. 

In her presentation, Helen will discuss some of the key aspects of early drug discovery and how utilising the Artios DcoDeR platform led to identification of Polθ inhibitors for treating malignant disease while leaving healthy cells intact. #cancerresearch #oncology #drugdevelopment

Repare Therapeutics is a company focused on developing precision oncology drugs for patients with genomically defined cancers.

Repare Therapeutics

Noetik is an AI-native biotechnology company leveraging machine learning for drug development.

Noetik

Turbine is a biotechnology company focused on developing innovative therapies for various diseases, including cancer.

Turbine

Moderna is a biotechnology company known for its mRNA technology platform and its work in developing vaccines and therapies, including for cancer.

Moderna

Incyte is a biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics for cancer and other diseases.

Incyte

FoRx Therapeutics is a biotechnology company focused on developing novel cancer therapies targeting DNA repair pathways.

FoRx Therapeutics

LXRepair is a biotechnology company specializing in the development of DNA repair-based therapies for cancer and other diseases.

LXRepair

Arcellx is a biotechnology company focused on developing novel cell therapies for the treatment of cancer and other diseases.

Arcellx

KSQ Therapeutics is a biotechnology company focused on using CRISPR-based functional genomics to discover and develop new drugs for cancer and other diseases.

KSQ Therapeutics

OncoHost is a biotechnology company specializing in the development of personalized immunotherapy and diagnostic solutions for cancer patients.

OncoHost

Artios is a biotechnology company focused on discovering and developing DDR therapeutics for treating various types of cancers.

Head of Clinical Trial Supply Management

Clinical Trials Supply Manager

Senior Clinical Supply Chain Manager

Senior Program Manager, Logistics and Clinical Supply

Study Manager, Logistics and Clinical Supply

Research Governance Coordinator

Nicola Middleton

Artios

Chief Business Officer

Tania Dimitrova

COO and interim CFO

Consultant CFO

Non Executive Director

Company Secretary

Corporate Finance

COO at Artios Pharma Ltd

Andrew Muncey

Director Of Operations

Head Of Operations

Head Of Finance

Consultant

VP of Finance

Consultant Finance Director

Interim Finance Director & Financial Controller positions

Corporate Finance, Life Sciences Group

Director of Operations at Artios Pharma Ltd

Sam Smart

Associate Director

Senior Principal Scientist

Principal Scientist, Medicinal Chemistry

Senior Scientist, Medicinal Chemistry

Scientist, Medicinal Chemistry

Sam Mann

Director of Finance

Director, Finance Business Support Team

Associate Director, Finance Business Support Team

Finance Manager, Financial Planning & Analysis

Business Partner, Stiefel Dermatology Business

Manager, R&D Finance

Senior Advisor - Portfolio Analyst

Senior Advisor - Internal Expense Pool Analyst

Financial Analyst

Director of Finance at Artios Pharma Ltd

Bonni Roark

Chief Operating Officer

Head of and formely Director of Drug Discovery

CEO at Artios Pharma Ltd

Niall Martin

Director of Clinical Development

Senior Director, Business Unit Operations Management (Oncology)

Director, Business Unit Operations Management (Oncology)

Project Director

Senior Project Manager - Early Phase Oncology

Head of Operations / Senior Project Manager

Clinical Project/Alliance Management (contract)

VP, International Projects

Clinical Project Management - Director Role

Study Delivery Leader

International Clinical Research Associate

Clinical Research Associate

Director of Clinical Development at Artios Pharma Ltd

Kirsty Mackay

Director, Legal Counsel

Director Legal

Legal Counsel

Commercial Counsel

In-house lawyer

Solicitor

Trainee Solicitor

Fiona Holloway-Stone

Director of Translational Science at Artios Pharma

Deputy Laboratory Head

Senior Bioscientist Drug Discovery

Post-Doctoral Research Associate Discovery Medicine

Postdoctoral Researcher Clinical and Experimental Pharmacology

PhD Graduate Student in Cell Biology

Director of Translational Science

Sarah Holt

Director of Quality

Senior Manager, Quality Assurance, GCP

Quality Assurance Manager, GCP

Senior Quality Assurance Officer

Assistant Quality Assurance Manager

Quality Manager

Jose Quintela

Director Clinical Development

Director Clinical Operations

Senior Director Project Management

Director Clinical Operations Strategy

Associate Director Quality and Risk Management

Clinical Operations Manager

Clinical Operations Quality Manager

Project Manager

Global Clinical Training Manager

European Clinical Trainer

Clinical Trainer

Regulatory Affairs Associate

Lucy Thomson

Director of Regulatory Affairs

Associate Director US/CAN Regulatory Affairs

Associate Director Western Europe Regulatory Affairs

Associate Director, Regulatory Affairs

Senior Manager, Regulatory Affairs

Regulatory Project Manager

Senior Advisor, Regulatory Affairs

Director of Regulatory Affairs, Artios Pharma Ltd.

Claire Devlin

Principal Scientist

Postdoctoral Research Fellow

Ph.D. student

Graduate Fellow

Master degree student - internship

Bachelor of Science Internship

Associate Director at Artios Pharma Ltd

Marco Ranzani

Chief Financial Officer

Board Member

Member

CFO, Artios | Board Member | CHIEF Member

Christine Silverstein

Director Of Bioinformatics and Omics Sciences

Senior Principal Scientist, Bioinformatics

Principal Scientist, Bioinformatics

Informatics Analyst (Associate Principal Informatician), R&D Informatics

Senior Bioinformatics Analyst

Computational Biology Analyst

Bioinformatician

Using Data to Fight Cancer | Director | Executive MBA

Suraj Menon

Chief Scientific Officer

Senior Director, Bioscience, Oncology iMED

Senior Project Leader, Oncology

Research Director

Chief Scientific Officer at Artios Pharma Ltd

Graeme Smith

Director of DDR Biology

Senior Scientist

PhD and Postdoctoral Researcher

Research Assistant

Undergraduate Student

Undergraduate Research Assistant

Director of DDR Biology at Artios Pharma Ltd

Eeson Rajendra

Member Board of Directors and Audit Chair

Chief Financial Officer / Corporate Director

Nora Brennan

Director, Business Development

Director, Corporate Development

Principal

Manager

Senior Consultant

PhD Candidate in Chemical Physics

General Chemistry Laboratory Teaching Assistant

Senior Fellow

Fellow

Science Policy Intern

Business Development at Artios

Colleen Sadin

news impact assignment basic	general	May 6, 2024 7:46 AM	dab675be
public peers	general	May 6, 2024 7:46 AM	0f3875a2
news daily refresh	general	Jul 25, 2024 12:00 PM	4640b5ee
news processing daily refresh	general	May 21, 2024 2:53 AM	f6ef1cb9
news impact assignment daily	general
news processing basic	general	May 6, 2024 7:46 AM	9c6b2dcd
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	138926d2
crunchbase profile	general
li profile	general	May 6, 2024 7:46 AM	19b4e7db
translate crunchbase fundingrounds	general
peers	general
news basic	general	May 6, 2024 7:46 AM	d5e81c1d
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:ARTIOS

Artios